Y. Kim

Publications199
h-index25
Citations2,065
Highly Influential Citations77
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • W. Sandborn
  • 1,901 Publications, 94,323 Citations
  • B. Ye
  • 407 Publications, 4,689 Citations
  • S. Yang
  • 322 Publications, 7,562 Citations
  • J. Cheon
  • 445 Publications, 7,407 Citations
  • Publications
  • Influence
Clinical Characteristics of Colonic Diverticulosis in Korea: A Prospective Study
Background/Aims The prevalence of colonic diverticulosis has been reported to be lower in Korea than in Western countries. This disease also shows markedly different characteristics in the Korean… Expand
  • 88
  • 11
  • PDF
Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea
Objective: To evaluate the safety and efficacy of CT-P13 (Remsima®) in patients with inflammatory bowel disease (IBD) in South Korea. Methods: This post-marketing study included patients with active… Expand
  • 95
  • 7
Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers
OBJECTIVES:It is difficult to diagnose intestinal Behçet's disease (BD) due to various extraintestinal manifestations emerging at different time points in the disease course and a lack of reliable… Expand
  • 95
  • 4
Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet's disease
Background: There is no disease activity index (DAI) currently available that can objectively assess the disease status of intestinal Behcet's disease (BD). The aim of this study was to develop a… Expand
  • 72
  • 3
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Infliximab is currently used for the treatment of moderate‐to‐severe ulcerative colitis (UC) with an inadequate response to conventional agents. The efficacy and safety of infliximab in Korean… Expand
  • 58
  • 3
Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
Background/Aims For decades, thiopurines have been the mainstay of inflammatory bowel disease (IBD) treatment and will play an important role in the future. However, complex metabolism and various… Expand
  • 43
  • 3
  • PDF
Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
Purpose The aim of this study was to assess the expressions of CD44 and CD133 in colorectal cancer tissue by using immunohistochemical staining and to analyze the clinical significance of the… Expand
  • 30
  • 3
  • PDF
Second Korean guidelines for the management of ulcerative colitis
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of… Expand
  • 29
  • 3
  • PDF
RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls
Background: Aberrant gene expression in the gut mucosa might contribute to the initiation and progression of Crohn's disease (CD). RNA sequencing (RNA-seq) provides precise measurements of expression… Expand
  • 18
  • 3
Taxus metabolomics: methyl jasmonate preferentially induces production of taxoids oxygenated at C-13 in Taxus x media cell cultures.
Cells from suspension cultures of Taxus cuspidata were extracted with pentane as a source of relatively non-polar taxoids. Of the 13 taxoids identified in this fraction, eight were oxygenated at C-14… Expand
  • 94
  • 2